Tom Mjörndal

2.6k total citations
59 papers, 2.0k citations indexed

About

Tom Mjörndal is a scholar working on Toxicology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tom Mjörndal has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 11 papers in Psychiatry and Mental health and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tom Mjörndal's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical studies and practices (5 papers). Tom Mjörndal is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmaceutical studies and practices (5 papers). Tom Mjörndal collaborates with scholars based in Sweden, Norway and United States. Tom Mjörndal's co-authors include Rune Dahlqvist, Martin Bäckström, Staffan Hägg, Olav Spigset, R. Dahlqvist, Klaus Hoeyer, Bert‐Ove Olofsson, Niels Lynöe, Rolf Adolfsson and Bengt‐Erik Wiholm and has published in prestigious journals such as Neurology, Biological Psychiatry and Journal of Applied Physiology.

In The Last Decade

Tom Mjörndal

58 papers receiving 1.9k citations

Peers

Countries citing papers authored by Tom Mjörndal

Since Specialization

Citations

This map shows the geographic impact of Tom Mjörndal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Mjörndal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Mjörndal more than expected).

Fields of papers citing papers by Tom Mjörndal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Mjörndal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Mjörndal. The network helps show where Tom Mjörndal may publish in the future.

Co-authorship network of co-authors of Tom Mjörndal

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Mjörndal. A scholar is included among the top collaborators of Tom Mjörndal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Mjörndal. Tom Mjörndal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urine Monitoring of Diazepam Abuse—New Intake or Not? 2008 ·Journal of Analytical Toxicology ·(unknown), Hans‐Åke Lakso, Mats Nilsson, Tom Mjörndal	8
2	Serum Levels of Olanzapine in a Non-Fatal Overdose 2007 ·Journal of Analytical Toxicology ·(unknown), Christopher L. Asplund, Mats Nilsson, Hans‐Åke Lakso, Tom Mjörndal, Staffan Hägg	8
3	High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia 2006 ·International Clinical Psychopharmacology ·Staffan Hägg, (unknown), Tom Mjörndal, Rolf Adolfsson	119
4	The Ethics of Research Using Biobanks 2005 ·Archives of Internal Medicine ·Klaus Hoeyer, Bert‐Ove Olofsson, Tom Mjörndal, Niels Lynöe	88
5	Under‐reporting of serious adverse drug reactions in Sweden 2004 ·Pharmacoepidemiology and Drug Safety ·Martin Bäckström, Tom Mjörndal, R. Dahlqvist	104
6	Sepsis as a Possible Adverse Drug Reaction in Patients With Rheumatoid Arthritis Treated With TNFα Antagonists 2004 ·JCR Journal of Clinical Rheumatology ·(unknown), Tom Mjörndal, Solbritt Rantapää‐Dahlqvist	16
7	Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding 2003 ·Psychoneuroendocrinology ·Anna‐Carin Wihlbäck, Inger Sundström Poromaa, Marie Bixo, Per Allard, Tom Mjörndal, Olav Spigset	40
8	1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden 2002 ·Journal of Hypertension ·Mats Persson, Bo Carlberg, Tom Mjörndal, Kjell Asplund, (unknown), Lars Lindholm	35
9	Adverse drug reactions as a cause for admissions to a department of internal medicine 2002 ·Pharmacoepidemiology and Drug Safety ·Tom Mjörndal, (unknown), Staffan Hägg, Martin Bäckström, Bengt‐Erik Wiholm, Anders Wåhlin, Rune Dahlqvist	165
10	Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis 2002 ·Pharmacoepidemiology and Drug Safety ·Martin Bäckström, Staffan Hägg, Tom Mjörndal, R. Dahlqvist	34
11	Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment 2001 ·Psychoneuroendocrinology ·Marie Bixo, Per Allard, Torbjörn Bäckström, Tom Mjörndal, Sigrid Nyberg, Olav Spigset, Inger Sundström Poromaa	15
12	Effect of caffeine on clozapine pharmacokinetics in healthy volunteers 2000 ·British Journal of Clinical Pharmacology ·Staffan Hägg, Olav Spigset, Tom Mjörndal, Rune Dahlqvist	50
13	Serotonin 5-HT2A Receptor Binding in Platelets From Patients With Alzheimer's Disease or Vascular Dementia 2000 ·International Psychogeriatrics ·Olav Spigset, (unknown), Tom Mjörndal, Sture Eriksson	7
14	Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy 1999 ·Biological Psychiatry ·Kenneth Smedh, Olav Spigset, Per Allard, Tom Mjörndal, Rolf Adolfsson	21
15	Absence of interaction between erythromycin and a single dose of clozapine 1999 ·European Journal of Clinical Pharmacology ·Staffan Hägg, Olav Spigset, Tom Mjörndal, (unknown), (unknown), R. Dahlqvist	31
16	Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers 1998 ·Biological Psychiatry ·Olav Spigset, Per Allard, Tom Mjörndal	24
17	The Effect of Fluvoxamine on Serum Prolactin and Serum Sodium Concentrations 1997 ·Journal of Clinical Psychopharmacology ·Olav Spigset, Tom Mjörndal	30
18	Effect of fluvoxamine on platelet 5-HT 2A receptors as studied by [ 3 H]lysergic acid diethylamide ([ 3 H]LSD) binding in healthy volunteers 1997 ·Psychopharmacology ·Olav Spigset, Tom Mjörndal	10
19	Effects of cyanide on the striatal dopamine receptor binding in the rat 1993 ·European Journal of Pharmacology Environmental Toxicology and Pharmacology ·Gudrun Cassel, Tom Mjörndal, Sven‐Åke Persson, (unknown)	1
20	Time‐related changes in serum perphenazine, striatal³H‐spiperone binding and regional brain acid metabolites of dopamine and 5‐hydroxy‐tryptamine after a single dose of perphenazine 1990 ·Fundamental and Clinical Pharmacology ·Tom Mjörndal, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact